Abstract:The FGFR3 :: TACC3 fusion has been reported in subsets of diverse cancers including urothelial and squamous cell carcinomas (SCC). However, the morphology of FGFR3 :: TACC3 -positive head and neck carcinomas has not been well studied and it is unclear if this fusion represents a random event, or if it might characterize a morphologically distinct tumor type. We describe nine FGFR3 :: TACC3 fusion–positive head and neck carcinomas affecting six males and three females aged 38 to 89 years (median, 59). The tumors originated in the sinonasal tract ( n = 4), parotid gland ( n = 2), and one case each in the oropharynx, submandibular gland, and larynx. At last follow-up (9–21 months; median, 11), four patients developed local recurrence and/or distant metastases, two died of disease at 11 and 12 months, one died of other cause, one was alive with disease, and two were disease-free. Three of six tumors harbored high risk oncogenic HPV infection (HPV33, HPV18, one unspecified). Histologically, three tumors revealed non-keratinizing transitional cell-like or non-descript morphology with variable mixed inflammatory infiltrate reminiscent of mucoepidermoid or DEK :: AFF2 carcinoma (all were HPV-negative), and three were HPV-associated (all sinonasal) with multiphenotypic (1) and non-intestinal adenocarcinoma (2) pattern, respectively. One salivary gland tumor showed poorly cohesive large epithelioid cells with prominent background inflammation and expressed AR and GATA3, in line with a possible salivary duct carcinoma variant. Two tumors were conventional SCC. Targeted RNA sequencing revealed an in-frame FGFR3 :: TACC3 fusion in all cases. This series highlights heterogeneity of head and neck carcinomas harboring FGFR3 :: TACC3 fusions, which segregates into three categories: (1) unclassified HPV-negative category, morphologically distinct from SCC and other entities; (2) heterogeneous group of HPV-associated carcinomas; and (3) conventional SCC. A driver role of the FGFR3 :: TACC3 fusion in the first category (as a potential distinct entity) remains to be further studied. In the light of available FGFR -targeting therapies, delineation of these tumors and enhanced recognition is recommended.

A Case Series of Three Soft Tissue Malignant Neoplasms with CRTC1-TRIM11 Fusion in the Head and Neck

Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion: a case report

Ulcerated CRTC1::TRIM11 cutaneous tumor with metastases

MED15::ATF1-rearranged tumor: a novel cutaneous tumor with melanocytic differentiation

Case report: Adult NTRK-rearranged spindle cell neoplasms with TPM3-NTRK1 fusion in the pelvic

A Rare Case of Malignant Triton Tumor Without Associated Neurofibromatosis

Desmoplastic Small Round Cell Tumor of the Head and Neck: A Clinicopathological, Immunohistochemical and Molecular Analysis of Three Cases with Literature Review

Novel NCOA2/3-rearranged low-grade fibroblastic spindle cell tumors: A report of five cases

Primary NTRK-rearranged Spindle Cell Neoplasm of the Lung A Clinicopathologic and Molecular Analysis of 3 Cases

Primary Cutaneous Epithelioid Mesenchymal Tumor With a Novel ATP2B4::GLI1 Gene Fusion

Identification of BRAF, CCND1, and MYC Mutations in a Patient with Multiple Primary Malignant Tumors: a Case Report and Review of the Literature

NTRK -rearranged spindle cell neoplasms: a clinicopathological and molecular study of 13 cases with peculiar characteristics at one of the largest institutions in China

NR1D1-rearranged soft tissue tumour: A clinicopathological and molecular analysis of four additional cases

A Rare Case of a Primary Cutaneous Collision Tumor Comprising Malignant Melanoma and Rhabdomyosarcoma

Pediatric Mesenchymal Tumor With MN1::TAF3 Fusion

NTRK3-EML4-rearranged spindle cell tumor with co-expression of S100 and CD34: an unusual mesenchymal tumor in the spectrum of the bland-looking spindle cell lesions of the oral cavity

TRK -rearranged spindle cell neoplasm: Initial observation of imaging appearance and clinicopathologic correlation

A novel TMTC2-NTRK3 fusion in undifferentiated high-grade pleomorphic sarcoma

Fusion‐driven cutaneous and superficial mesenchymal and adnexal tumors—A clinicopathologic and molecular study of 15 cases, including a novel case of ACTB::ZMIZ2‐rearranged adnexal carcinoma

Case Report: An NTRK1 fusion-positive embryonal rhabdomyosarcoma: clinical presentations, pathological characteristics and genotypic analyses

FGFR3::TACC3 fusions in head and neck carcinomas: a study of nine cases highlighting phenotypic heterogeneity, frequent HPV association, and a morphologically distinct subset in favor of a putative entity